He Chen
Impact in
- Molecular Biology top 5%
- Protein Degradation and Inhibitors
- Ubiquitin and proteasome pathways
- Circular RNAs in diseases
- Advanced biosensing and bioanalysis techniques
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
Papers in
-
- Advanced biosensing and bioanalysis techniques 13
- Protein Degradation and Inhibitors 11
- Ubiquitin and proteasome pathways 8
- RNA modifications and cancer 6
- RNA Research and Splicing 5
- CRISPR and Genetic Engineering 5
- Co-authors
- Jian Jin (13 shared papers)H. Ümit Kanıskan (11 shared papers)Jing Liu (9 shared papers)Wenyi Wei (7 shared papers)Xian Chen (7 shared papers)Ling Xie (6 shared papers)Fanye Meng (3 shared papers)Yudao Shen (3 shared papers)
- Journals
- Journal of the American Chemical Society (8 papers)Analytical Chemistry (4 papers)Journal of Cellular Biochemistry (2 papers)Frontiers in Pharmacology (2 papers)ACS Applied Materials & Interfaces (2 papers)
- Partner nations
- ChinaUnited StatesUruguay
In The Last Decade
He Chen
79 papers receiving 1.9k citations
He Chen's Hit Papers
Peers
Comparison fields: 5 of 114
- Molecular Biology 1.5k
- Cancer Research 273
- Hematology 175
- Oncology 383
- Parasitology 87
Countries citing papers authored by He Chen
This map shows the geographic impact of He Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by He Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites He Chen more than expected).
Fields of papers citing papers by He Chen
This network shows the impact of papers produced by He Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by He Chen. The network helps show where He Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside He Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 83 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Cancer Selective Target Degradation by Folate-Caged PROTACs Hit paper breakdown → | 2021 | 219 |
| 2 | 2021 | 178 | |
| 3 | 2021 | 96 | |
| 4 | 2021 | 82 | |
| 5 | 2019 | 76 | |
| 6 | 2015 | 68 | |
| 7 | 2007 | 68 | |
| 8 | 2008 | 64 | |
| 9 | 2016 | 58 | |
| 10 | 2015 | 52 | |
| 11 | 2023 | 50 | |
| 12 | 2016 | 43 | |
| 13 | 2022 | 42 | |
| 14 | 2018 | 41 | |
| 15 | 2020 | 37 | |
| 16 | 2021 | 34 | |
| 17 | 2020 | 29 | |
| 18 | 2022 | 28 | |
| 19 | 2015 | 27 | |
| 20 | 2021 | 26 |
About He Chen
He Chen is a scholar working on Molecular Biology, Cancer Research, Biomedical Engineering, Oncology and Radiology, Nuclear Medicine and Imaging, having authored 83 papers that have together received 1.9k indexed citations. Recurring topics across this work include Advanced biosensing and bioanalysis techniques (13 papers), Protein Degradation and Inhibitors (11 papers), Ubiquitin and proteasome pathways (8 papers), RNA modifications and cancer (6 papers), Monoclonal and Polyclonal Antibodies Research (6 papers), RNA Research and Splicing (5 papers), CRISPR and Genetic Engineering (5 papers) and Biosensors and Analytical Detection (5 papers). The work is most often cited by research in Molecular Biology (1.5k citations), Cancer Research (273 citations), Hematology (175 citations), Oncology (383 citations) and Parasitology (87 citations). He Chen has collaborated with scholars based in China, United States and Uruguay. Frequent co-authors include Jian Jin, H. Ümit Kanıskan, Jing Liu, Wenyi Wei, Xian Chen, Ling Xie, Fanye Meng, Yudao Shen, Yi Liu and Peiling Li. Their work appears in journals such as Journal of the American Chemical Society, Analytical Chemistry, Journal of Cellular Biochemistry, Frontiers in Pharmacology and ACS Applied Materials & Interfaces.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.